Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifamycin Sodium Injection

Approval Number

国药准字H32025722

Company江苏吴中医药集团有限公司苏州制药厂

Registration Date

November 21, 2022

Drug Information

Generic Name

利福霉素钠注射液

Dosage Form

注射剂

Strength

2ml:0.125g(12.5万单位)

Drug Type

化学药品

Registration Date

November 21, 2022

Company Information

Applicant Company

Company Name江苏吴中医药集团有限公司苏州制药厂

Company Address

苏州市吴中区东吴南路2-1号

Manufacturing Company

Company Name江苏吴中医药集团有限公司苏州制药厂

Company Address

苏州市吴中区东吴南路2-1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

利福霉素钠注射液 - NMPA 批准文号 | MedPath